Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes-Reference-Cited by-同舟云学术

Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes

Published:2020-05-04 Issue:4 Volume:132 Page:337-345
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Lingvay Ildiko¹,Beetz Nadine²^ORCID,Sennewald Regina²^ORCID,Schuler-Metz Annette³^ORCID,Bertulis Julia³^ORCID,Loley Christina⁴,Lang Benjamin⁴,Lippert Caroline³,Lee Jisoo⁵,Manning Linda Shapiro⁶^ORCID,Terada Derek⁶

Affiliation:

1. Department of Internal Medicine/Endocrinology and Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA

2. Global Clinical Operations, Early Trials, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany

3. Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany

4. Biostatistics and Data Sciences, Clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany

5. Clinical Development & Cardiometabolism and Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim, Germany

6. Clinical Development & Medical Affairs - Cardiometabolism, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA

Funder

Boehringer Ingelheim Pharmaceuticals, Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1750228

Reference37 articles.

1. WHO. Diabetes. Key Facts; 2018. [cited 2019 Oct 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.

2. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

3. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability-indicating HPLC for remogliflozin, vildagliptin, and metformin: Method development, validation, and greenness;Annales Pharmaceutiques Françaises;2024-06

2. Therapeutic potentials of glucose-dependent insulinotropic polypeptide (GIP) in T2DM: Past, present, and future;Advances in Protein Chemistry and Structural Biology;2024

3. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review;Frontiers in Endocrinology;2023-12-19

4. Bioequivalence assessment of two formulations of empagliflozin in healthy adult subjects;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2023-11-17

5. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30